Argosy Research Balance Sheet Health
Financial Health criteria checks 6/6
Argosy Research has a total shareholder equity of NT$4.3B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$5.3B and NT$1.0B respectively. Argosy Research's EBIT is NT$826.8M making its interest coverage ratio -15.5. It has cash and short-term investments of NT$1.4B.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -15.5x |
Cash | NT$1.38b |
Equity | NT$4.30b |
Total liabilities | NT$1.03b |
Total assets | NT$5.32b |
Recent financial health updates
Recent updates
A Look At The Intrinsic Value Of Argosy Research Inc. (GTSM:3217)
Apr 29Will Argosy Research (GTSM:3217) Become A Multi-Bagger?
Mar 18Is Argosy Research (GTSM:3217) Using Too Much Debt?
Feb 28How Does Argosy Research Inc. (GTSM:3217) Fare As A Dividend Stock?
Feb 10Calculating The Fair Value Of Argosy Research Inc. (GTSM:3217)
Jan 26Is There More To The Story Than Argosy Research's (GTSM:3217) Earnings Growth?
Jan 11Are Strong Financial Prospects The Force That Is Driving The Momentum In Argosy Research Inc.'s GTSM:3217) Stock?
Dec 24The 24% Return On Capital At Argosy Research (GTSM:3217) Got Our Attention
Dec 06Argosy Research (GTSM:3217) Has Rewarded Shareholders With An Exceptional 999% Total Return On Their Investment
Nov 18Financial Position Analysis
Short Term Liabilities: 3217's short term assets (NT$3.0B) exceed its short term liabilities (NT$917.4M).
Long Term Liabilities: 3217's short term assets (NT$3.0B) exceed its long term liabilities (NT$111.0M).
Debt to Equity History and Analysis
Debt Level: 3217 is debt free.
Reducing Debt: 3217 has no debt compared to 5 years ago when its debt to equity ratio was 6.1%.
Debt Coverage: 3217 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3217 has no debt, therefore coverage of interest payments is not a concern.